KL-6 serum levels are raised in CTD-ILD (including pSS-ILD) patients with respect to non-ILD CTD patients and correlate with the severity of ILD assessed by HRCT and PFT, thus reflecting the extent of the pulmonary damage [41]. The gene discussed is MUC1; the disease is interstitial lung disease.